Glycyrrhizic Acid-Loaded Poloxamer and HPMC-Based In Situ Forming Gel of Acacia Honey for Improved Wound Dressing: Formulation Optimization and Characterization for Wound Treatment
Citations Over TimeTop 10% of 2024 papers
Abstract
The present study aims to formulate a stimuli-responsive in situ hydrogel system to codeliver acacia honey and glycyrrhizic acid for topical application that will aid in absorbing wound exudates, control microbial infestation, and produce angiogenic and antioxidant effects to accelerate wound healing. Therefore, both the natural active constituents were incorporated within an in situ hydrogel composed of poloxamer and hydroxypropyl methylcellulose (HPMC), where the concentrations of the polymers were optimized using Design-Expert software considering optimum values of the dependent variables, gelation temperature (34-37 °C), gelation time (in situ hydrogel exhibited potent in vitro and ex vivo antioxidant effects, in vitro antimicrobial activities, and ex ovo angiogenic effects. Furthermore, the optimized formulation was found to be nontoxic while tested in the HaCaT cell line and acute dermal irritation and corrosion study. The findings of the in vivo wound-healing studies in experimental animal models showed complete wound closure within 15 days of treatment and accelerated development of the extracellular matrix. In addition, the antioxidant, antimicrobial, angiogenic, and wound-healing properties of acacia honey and glycyrrhizic acid coloaded in situ hydrogel were also found to be promising when compared to the standard treatments. Overall, it can be concluded that the optimized stimuli-responsive in situ hydrogel containing two natural compounds could be an alternative to existing topical formulations for acute wounds.
Related Papers
- → Use of factorial design in formulation and evaluation of intrarectal in situ gel of sumatriptan(2023)15 cited
- → Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clots(1996)7 cited
- → Performing a literature review(2012)3 cited
- Study on Formulation of Breviscapine in Situ Nasal Thermoreversible Gel(2013)
- Phase Transition of Poloxamer 407 : Poloxamer 407의 상전이(2000)